| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61789d2d87bbe3f5d51f6dbb4172cdcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d0446a5bd77c7da68216fc2e3f05d48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdf6b0de308c99f4eae7d44dfc192cc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22cf22a7f583beb67d54f1ff8b986ffe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09199a7dc0d290e5b5dba1baced8b1fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_855e573a059339daec02db7781d3a71b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42a59c5faed1d0699d86edc5a2eee671 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 |
| filingDate |
2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6fd870f22f4d760b36c93a88254018f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96b3933c31e0ae5670e25b9b649f7497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e667332536158d327c44446467d0f2ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3841ca8974c3e3c3a92f6a4a4c91471
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_825c41555a5a51b5ee637264a4ae1215 |
| publicationDate |
2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012066549-A1 |
| titleOfInvention |
Dipeptide analogs for treating conditions associated with amyloid fibril formation |
| abstract |
Dipeptide analogs comprising a tryptophan (Trp) moiety coupled to a beta-sheet breaker moiety derived from alpha-aminoisobutyric acid (Aib) are disclosed. The didpeptide analogs exhibit an improved performance in inhibiting amyloid fibril formation, as compared to previously described dipeptides. Compositions containing the didpetide analogs and uses thereof in treating amyloid-associated diseases and disorders are also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013189606-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10987400-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020219634-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993510-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8697634-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096645-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9630989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015521608-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8563273-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9717772-B2 |
| priorityDate |
2010-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |